Lilly diabetes drug helps patients shed average of 34 pounds in trial
Eli Lilly and Co. says a new clinical trial for its drug tirzepatide helped overweight diabetes patients lose an average of 15.7% of body weight, or 34.4 pounds, after 72 weeks. The drug is currently sold under the brand name Mounjaro for type 2 diabetes... Read More
